Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 256.00
+5.00 (1.99%)
Aug 27, 2026, 3:30 PM JST
Transgenic Group Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 13,636 | 13,174 | 13,005 | 13,083 | 11,429 | 12,576 |
Revenue Growth | 2.37% | 1.30% | -0.60% | 14.47% | -9.12% | 13.85% |
Gross Profit Gross Profit Growth | 2,539 | 2,433 | 2,167 | 2,248 | 1,994 | 3,835 |
Operating Income Operating Income Growth | 257 | 138 | -255 | 102 | -25 | 1,837 |
Net Income Net Income Growth | 33 | -77 | -1,089 | 4 | -409 | 1,876 |
Earnings Per Share EPS Growth | 1.98 | -4.62 | -65.47 | 0.24 | -24.28 | 109.31 |
EPS Growth | - | - | - | - | - | 247.70% |
| Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Drug Discovery Support Business Drug Discovery Support Business Growth | 2,259 | 1,896 | 2,318 | 2,253 | 4,767 |
Unallocated Adjustment Amount Unallocated Adjustment Amount Growth | -6.7 | -6.44 | -6.72 | -5.47 | -13.3 |
Investment and Consulting Business Investment and Consulting Business Growth | 10,922 | 11,115 | 10,772 | 9,182 | - |
Total Total Growth | 13,174 | 13,005 | 13,083 | 11,430 | 12,577 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,259 | 2,134 | 2,555 | 2,478 | 3,459 | 4,623 |
Total Debt Total Debt Growth | 2,604 | 2,088 | 2,574 | 2,255 | 2,416 | 1,818 |
Net Cash (Debt) Net Cash Growth | -345 | 46 | -19 | 223 | 1,043 | 2,805 |
Net Cash Growth | - | - | - | -78.62% | -62.82% | 170.49% |
Net Cash Per Share Net Cash Per Share Growth | -20.72 | 2.76 | -1.14 | 13.27 | 61.92 | 163.41 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 25 | 94 | -392 | -1,430 | 1,789 |
Capital Expenditures CapEx Growth | - | -68 | -175 | -264 | -306 | -532 |
Free Cash Flow Free Cash Flow Growth | - | -43 | -81 | -656 | -1,736 | 1,257 |
Free Cash Flow Growth | - | - | - | - | - | 16.71% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 18.62% | 18.47% | 16.66% | 17.18% | 17.45% | 30.49% |
Operating Margin | 1.88% | 1.05% | -1.96% | 0.78% | -0.22% | 14.61% |
Pretax Margin | -0.65% | -1.56% | -5.19% | 0.33% | -2.90% | 22.00% |
Profit Margin | 0.24% | -0.58% | -8.37% | 0.03% | -3.58% | 14.92% |
FCF Margin | - | -0.33% | -0.62% | -5.01% | -15.19% | 9.99% |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.000 | 3.000 | 3.000 |
Dividend Per Share Growth | 0% | 0% | 0% |
Dividend Yield | 1.24% | 0.91% | 0.73% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 27, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 126.67 | - | - | 999.77 | - | 3.81 |
Forward PE | - | 14.76 | 14.76 | 14.76 | 14.76 | 14.76 |
P/FCF Ratio | - | - | - | - | - | 5.69 |
PS Ratio | 0.31 | 0.32 | 0.23 | 0.31 | 0.49 | 0.57 |